Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
PT Diagnos Laboratorium Utama TbkISX:DGNS -1.67%21 Net Debt Paydown Yield % is 0.00% as of Aug. 08, 2026. GuruFocus rates ISX:DGNS with a GF Score™ of 21/100. The stock has 1 warning sign investors should review. Among 196 Medical Diagnostics & Research companies, PT Diagnos Laboratorium Utama Tbk ranks worse than 510203.57% on this metric.
Net Debt Paydown Yield % is a metric that evaluates the total amount of debt a company has paid in relation to its market capitalization. It is a measure of a company's willingness and ability to reduce its debt.
PT Diagnos Laboratorium Utama Tbk does not have enough data to calculate Net Debt Paydown Yield %.
PT Diagnos Laboratorium Utama Tbk (ISX:DGNS) Net Debt Paydown Yield % Explanation
Net Debt Paydown Yield % is the change in average of four quarters of company's total debt over a company's market cap. Assuming the total value of a company remains that same, shareholder value is increased as debt is reduced. In other words, it is a measure of the willingness and ability of a firm's management to pay down debt. Companies that have high debt paydown yields indicate that they are more aggressive with paying down debt.
In the calculation of Net Debt Paydown Yield %, we use the reductions of TTM average total debt one-year-ago and TTM average total debt at present, divided by its Market Cap.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PT Diagnos Laboratorium Utama Tbk Net Debt Paydown Yield % Chart
PT Diagnos Laboratorium Utama Tbk Annual Data
Trend
Net Debt Paydown Yield %
PT Diagnos Laboratorium Utama Tbk Semi-Annual Data
Net Debt Paydown Yield %
ISX:DGNS vs TMO, DHR, IDXX: Net Debt Paydown Yield % Comparison
For the Diagnostics & Research subindustry, PT Diagnos Laboratorium Utama Tbk's Net Debt Paydown Yield %, along with its competitors' market caps and Net Debt Paydown Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PT Diagnos Laboratorium Utama Tbk Net Debt Paydown Yield % vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, PT Diagnos Laboratorium Utama Tbk's Net Debt Paydown Yield % distribution charts can be found below:
* The bar in red indicates where PT Diagnos Laboratorium Utama Tbk's Net Debt Paydown Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* All the data are calculated by TTM values. Note that if a companies is traded in several exchanges, then we calculate the company level data for Net Debt Paydown Yield % using the primary share class stock data. The calculation result in definition page is for demonstration purpose only, and it's showing the share class level data. Therefore, the numbers in the calculation may differ from elsewhere if the stock is not a primary share.
What does a Net Debt Paydown Yield % of 0.00% mean?
PT Diagnos Laboratorium Utama Tbk (ISX:DGNS) has a Net Debt Paydown Yield % of 0.00% as of Aug. 08, 2026. Net Debt Paydown Yield is a metric that evaluates the total amount of debt a company has paid in relation to its market capitalization. This metric provides insight into a company's willingness and ability to reduce its debt using free cash flow. View historical data on PT Diagnos Laboratorium Utama Tbk and its competitors. According to the industry distribution chart, PT Diagnos Laboratorium Utama Tbk ranks #999999 out of 196 companies in the Medical Diagnostics & Research industry.
Is PT Diagnos Laboratorium Utama Tbk's Net Debt Paydown Yield % too high?
PT Diagnos Laboratorium Utama Tbk's current Net Debt Paydown Yield % is 0.00%. Based on the distribution chart, PT Diagnos Laboratorium Utama Tbk ranks #999999 out of 196 companies in the Medical Diagnostics & Research industry, which is in the bottom quartile relative to peers. Overall, PT Diagnos Laboratorium Utama Tbk has a GF Score™ of 21/100, reflecting its overall financial health beyond just this single metric.
How does PT Diagnos Laboratorium Utama Tbk's Net Debt Paydown Yield % compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, PT Diagnos Laboratorium Utama Tbk ranks #999999 out of 196 companies for Net Debt Paydown Yield %. This places PT Diagnos Laboratorium Utama Tbk in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Debt Paydown Yield % for a Medical Diagnostics & Research company?
A good Net Debt Paydown Yield % depends on the Medical Diagnostics & Research industry context. However, Net Debt Paydown Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Debt Paydown Yield % mean?
A high Net Debt Paydown Yield % can signal that a stock is expensive relative to its fundamentals. Net Debt Paydown Yield is a metric that evaluates the total amount of debt a company has paid in relation to its market capitalization. This metric provides insight into a company's willingness and ability to reduce its debt using free cash flow. View historical data on PT Diagnos Laboratorium Utama Tbk and its competitors. PT Diagnos Laboratorium Utama Tbk's current Net Debt Paydown Yield % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT Diagnos Laboratorium Utama Tbk stock overvalued right now?
PT Diagnos Laboratorium Utama Tbk (ISX:DGNS) has a current Net Debt Paydown Yield % of 0.00%. The current Net Debt Paydown Yield % is 0.00%. PT Diagnos Laboratorium Utama Tbk's overall GF Score™ is 21/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Debt Paydown Yield % calculated?
Net Debt Paydown Yield % is calculated from a company's financial statements. For PT Diagnos Laboratorium Utama Tbk (ISX:DGNS), the current Net Debt Paydown Yield % is 0.00% as of Aug. 08, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
PT Diagnos Laboratorium Utama Tbk operates in the field of Health Support Services and Private Clinic Activities. It provides health support service activities managed by both the government and the private sector, such as health laboratories in the form of X-Ray Laboratories, and other diagnostic imaging centers, as well as blood testing, private clinics, pharmaceutical warehouses, eye banks, blood banks, sperm banks, organ transplant banks, and other medical support services. Its products and services include Clinical Pathology Laboratory, Anatomical Pathology Laboratory, Genomics Laboratory, Homecare Health Services, Corporate Health Services, Microbiology Laboratory, and Research Services.
21GF Score
Get the complete analysis for ISX:DGNS
Net Debt Paydown Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ISX:DGNS has been successfully added to your 
